phrykt

Encompass Health Corp (EHC): who owns it and who trades it

As of Nov 16, 2026, EHC insiders reported 18 open-market sales worth $47.8M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Mark J Tarr (CEO), with $38.5M. 6 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Encompass Health

From the latest filings

Overall: more selling than buying. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns EHC

594 funds and institutions reported EHC shares worth $9.6B at the end of Q2 2026, about 96% of the company. The largest holder is BlackRock, Inc. with 10.6%.

Funds and institutions (13F) 96%Everyone else 4%

10 largest owners, by share of the company

BlackRock, Inc.10.6%
T. Rowe Price Associates5.1%
Vanguard Portfolio Management LLC5.0%
Vanguard Capital Management LLC4.5%
Wellington Management Group LLP3.3%
State Street Corp3.2%
Citadel Advisors LLC2.6%
Alliancebernstein L.P.2.5%
Fuller & Thaler Asset Management, Inc.2.5%
Two Sigma Investments, LP2.3%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.10.48M10.57%$1.1B-3%
T. Rowe Price Associates5.06M5.10%$511M+10%
Vanguard Portfolio Management LLC4.92M4.96%$498M-1%
Vanguard Capital Management LLC4.48M4.51%$452M+0%
Wellington Management Group LLP3.28M3.31%$331M-15%
State Street Corp3.19M3.21%$322M+1%
Citadel Advisors LLC2.56M2.58%$259M+401%
Alliancebernstein L.P.2.47M2.49%$239M-6%
Fuller & Thaler Asset Management, Inc.2.46M2.48%$249M+10%
Two Sigma Investments, LP2.27M2.29%$229M+2%
Geode Capital Management, LLC1.89M1.91%$191M-0%
Dimensional Fund Advisors LP1.74M1.76%$176M+4%
Goldman Sachs Group Inc1.55M1.56%$157M-14%
Invesco Ltd.1.16M1.17%$117M-66%
Arrowstreet Capital, Limited Partnership1.16M1.17%$117M-2%
Norges Bank1.15M1.16%$117M–
William Blair Investment Management, LLC1.15M1.16%$116M+43%
Morgan Stanley1.15M1.16%$116M+28%
JPMorgan Chase & Co1.13M1.14%$115M–
Raymond James Financial Inc1.06M1.07%$108M-0%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, EHC insiders reported $0 of open-market purchases and $47.8M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$47.8M
18 trades, 6 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Aug 31, 2026
Filed Sep 1, 2026

Purchases and sales by month

$26.4M$26.4MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 31, 2026Andrew L PriceChief Accounting OfficerSale5,211$120.93$630KForm 4
Aug 31, 2026John Patrick DarbyVice presidentSale4,858$121.09$588KForm 4
Aug 10, 2026Douglas E ColtharpCFOSale18,869$125.38$2.4MForm 4
Aug 10, 2026Mark J TarrCEOSale171,569$125.46$21.5MForm 4
Aug 10, 2026Mark J TarrCEOSale1,579$126.06$199KForm 4
Aug 10, 2026John Patrick DarbyVice presidentSale8,906$125.95$1.1MForm 4
May 15, 2026Douglas E ColtharpCFOSale1$107.28$107Form 4
May 15, 2026Douglas E ColtharpCFOSale27,693$106.83$3MForm 4
May 11, 2026Patrick William TuerVice presidentSale682$104.56$71.3KForm 4
Mar 9, 2026Edmund FaySr. Vice Pres. and TreasSale11,937$107.00$1.3MForm 4
Feb 11, 2026Mark J TarrCEOSale6,057$111.89$678KForm 4
Feb 11, 2026Mark J TarrCEOSale10,954$110.92$1.2MForm 4
Feb 11, 2026Mark J TarrCEOSale15,584$110.07$1.7MForm 4
Feb 11, 2026Mark J TarrCEOSale13,231$108.80$1.4MForm 4
Feb 11, 2026Mark J TarrCEOSale16,216$108.03$1.8MForm 4
Feb 11, 2026Mark J TarrCEOSale87,745$113.09$9.9MForm 4
Feb 11, 2026Mark J TarrCEOSale213$113.58$24.2KForm 4
Feb 10, 2026Patrick William TuerVice presidentSale2,804$107.62$302KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Mark J TarrPresident & CEO, Director–$38.5MAug 10, 2026
Douglas E ColtharpEVP & Chief Financial Officer–$5.3MAug 10, 2026
John Patrick DarbyEVP, Gen Counsel & Secretary–$1.7MAug 31, 2026
Edmund FaySr. Vice Pres. and Treasurer–$1.3MMar 9, 2026
Andrew L PriceChief Accounting Officer–$630KAug 31, 2026
Patrick William TuerEVP, Chief Operating Officer–$373KMay 11, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

EHC short interest

Low short interest. 3.7% of EHC shares are sold short: about 1 share in 27. Over the last 12 reports the number of shares short went up 6%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 3.61M EHC shares were sold short, 3.7% of the shares outstanding, up 9.1% from the report before. At the average daily volume of 1.34M shares, buying them all back would take about 2.7 trading days (days to cover).

Shares short, % of all shares

3.68%May 15Oct 304.09%

Days to cover

2.7May 15Oct 305.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20263.61M3.68%+9%1.34M2.7
Oct 15, 20263.31M3.36%-5%941,8643.5
Sep 30, 20263.49M3.54%+16%981,8723.5
Sep 15, 20263.00M3.04%-7%728,9064.1
Aug 31, 20263.24M3.28%-1%873,3153.7
Aug 14, 20263.27M3.32%-10%1.16M2.8
Jul 31, 20263.65M3.70%-7%747,1744.9
Jul 15, 20263.92M3.95%+26%1.07M3.6
Jun 30, 20263.10M3.13%-1%1.43M2.2
Jun 15, 20263.15M3.17%-7%823,1213.8
May 29, 20263.37M3.39%-1%714,3634.7
May 15, 20263.41M3.44%No change1.04M3.3

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded EHC

Since Nov 17, 2024, 1 member of Congress reported 2 purchases and 2 sales of EHC. The latest was a sale by Lisa C. McClain on Oct 31, 2025, reported Nov 21, 2025.

Purchases 2Sales 2

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Oct 31, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseNov 21, 2025Report
Oct 30, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseNov 21, 2025Report
Oct 30, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseNov 21, 2025Report
Jul 22, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseAug 13, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Encompass Health company events

Encompass Health filed 13 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 6, 2026.

  1. Nov 6, 2026AnnouncementShared information with investors. Filing
  2. Oct 28, 2026ResultsReleased financial results. Filing
  3. Aug 13, 2026AnnouncementEncompass Health Corporation completed the issuance and sale of $100 million in of its 5.875% Senior Notes due 2034, along with the related guarantees of the Additional Notes by certain of the Company’s subsidiaries, in a private offering. Filing
  4. Aug 5, 2026ResultsReleased financial results. Filing
  5. Jun 1, 2026AgreementEncompass Health Corporation completed the issuance and sale of $500 million in of its 5.875% Senior Notes due 2034, along with the related guarantees of the Notes by certain of the Company’s subsidiaries, in a private offering. Filing
  6. May 15, 2026AgreementEncompass Health Corporation and certain of its subsidiaries, as guarantors, entered into a purchase agreement with Wells Fargo Securities, LLC, as the representative of the initial purchasers, with respect to a private offering by the Company of $500 million in of 5.875% senior notes due 2034… Filing
  7. May 11, 2026VoteReported shareholder vote results. Filing
  8. Apr 30, 2026ResultsReleased financial results. Filing
  9. Mar 10, 2026AgreementEncompass Health Corporation entered into the Credit Agreement, by and among the Company, certain of its subsidiaries, as guarantors, Truist Bank, as administrative agent and collateral agent, and various other lenders. Filing
  10. Feb 20, 2026LeadershipAmended an earlier report. Reported a change among its top officers or directors, or their pay. Filing
  11. Feb 5, 2026ResultsReleased financial results. Filing
  12. Feb 2, 2026LeadershipReported a change among its top officers or directors, or their pay. Filing
  13. Dec 1, 2025AnnouncementShared information with investors. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Encompass Health financials

Famous investors that hold EHC

6 of the 50 well-known investors we track reported holding EHC in their latest 13F filing. The largest position is Ken Griffin's, worth $310M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 20262.55M$310M0.2%-0%
Israel Englander · Millennium ManagementQ3 20261.59M$193M0.1%+97%
Jim Simons · Renaissance TechnologiesQ3 2026109,600$13.3M0.0%-37%
Steve Cohen · Point72 Asset ManagementQ3 202684,794$10.3M0.0%New
Paul Tudor Jones · Tudor Investment CorpQ3 202680,992$9.8M0.0%New
Ray Dalio · Bridgewater AssociatesQ3 202619,004$2.3M0.0%-54%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Encompass Health Corp (EHC) stock

Who owns the most EHC stock?

The largest reported owner of Encompass Health Corp (EHC) is BlackRock, Inc., with 10.6% of the company. In total, 594 funds and institutions reported holding EHC at the end of Q2 2026, together about 96% of the shares. See the largest owners.

Are EHC insiders buying or selling?

In the last 12 months, EHC insiders reported no open-market purchases and 18 sales worth $47.8M. The latest trade was on Aug 31, 2026. See every trade.

What is the short interest in EHC?

As of Oct 30, 2026, 3.61M EHC shares were sold short, 3.7% of the shares outstanding, up 9.1% from the report before. At the average daily volume of 1.34M shares, buying them all back would take about 2.7 trading days (days to cover). See the history.

Have members of Congress traded EHC?

Yes. 1 member of Congress reported 2 purchases and 2 sales of EHC since Nov 17, 2024. The latest was reported on Nov 21, 2025. See the trades.

Which famous investors hold EHC?

6 of the 50 well-known investors we track reported EHC in their latest 13F filing, including Ken Griffin, Israel Englander, Jim Simons. The largest position is worth $310M. See all holders.

Executive pay

Encompass Health's chief executive was paid a total of $10.3M for the year ended Dec 31, 2025, up 11% from $9.3M the year before. In the last 12 months, Encompass Health's executives and directors bought no stock on the open market and sold $47.8M.

Chief executive, total pay$10.3MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$20.6MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$2.9MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.